Global Dysmenorrhea Treatment Market to Cross ~USD 8 Billion by 2032
The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea treatment market. With more women pursuing medical care for menstrual discomfort, there is a growing demand for a wide range of treatment options, including over-the-counter painkillers and hormonal therapies. Furthermore, awareness campaigns and educational initiatives are playing a key role in breaking the stigma around the condition, promoting earlier diagnosis and treatment.
DelveInsight's Dysmenorrhea Treatment Market Insights report provides the current and forecast market analysis, individual leading dysmenorrhea treatment companies' market shares, challenges, dysmenorrhea treatment market drivers, barriers, trends, and key market dysmenorrhea treatment companies in the market.
Key Takeaways from the Dysmenorrhea Treatment Market Report As per DelveInsight estimates, North America is anticipated to dominate the global dysmenorrhea treatment market during the forecast period.
In the treatment segment of the dysmenorrhea treatment market, the devices category accounted for the largest market share in 2024.
Notable dysmenorrhea treatment companies such as Johnson & Johnson Services Inc., iPulse Medical Ltd., Bridges CHC, LLC., AbbVie Inc., Myoovi Ltd., Rael Inc., Abbott, Pfizer Inc., TensCare Ltd. (UK), Beurer GmbH (Germany), BPL Medical Technologies, Cora, Carex Health Brands (USA), Sumitovant Biopharma, Emcure Pharmaceuticals, Everteen, Samphire Neuroscience, Mirapulse, Welme, Nomisk, and several others are currently operating in the dysmenorrhea treatment market.
and several others are currently operating in the dysmenorrhea treatment market. In September 2024, Organon K.K., a global healthcare company focused on women's health, announced that it had achieved the primary endpoint in a domestic Phase III clinical trial evaluating the efficacy and safety of OG-8276A for dysmenorrhea. Based on the trial results, the company prepared to apply for marketing approval and launch in Japan.
To read more about the latest highlights related to the dysmenorrhea treatment market, get a snapshot of the key highlights entailed in the Global Dysmenorrhea Treatment Market Report
Dysmenorrhea Treatment Overview
Dysmenorrhea, commonly known as menstrual cramps, is managed through a combination of pharmacological and non-pharmacological treatments aimed at relieving pain and improving quality of life. First-line pharmacological therapies typically include nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which work by reducing prostaglandin production, one of the main causes of uterine contractions and pain during menstruation. For individuals who do not respond adequately to NSAIDs or have more severe symptoms, hormonal therapies like combined oral contraceptives, progestin-only pills, hormonal intrauterine devices (IUDs), or contraceptive implants may be prescribed to regulate or suppress ovulation and lessen menstrual flow, thereby reducing pain. In cases of secondary dysmenorrhea, where an underlying condition such as endometriosis or fibroids is present, treatment may be more complex and involve surgical interventions or disease-specific therapies.
Non-pharmacological approaches also play an important role in dysmenorrhea management. Lifestyle modifications such as regular exercise, stress reduction, and dietary changes, like reducing caffeine and fat intake, may help alleviate symptoms. Heat therapy (using heating pads or hot baths), acupuncture, yoga, and transcutaneous electrical nerve stimulation (TENS) are complementary therapies that some individuals find beneficial. Additionally, education and counseling can empower individuals to better manage their symptoms and seek timely medical intervention when needed. As awareness about menstrual health grows, there is an increasing emphasis on personalized treatment approaches that consider the individual's medical history, symptom severity, and lifestyle preferences.
Dysmenorrhea Treatment Market Insights
North America dominated the dysmenorrhea treatment market in 2024, supported by several critical drivers. The region benefits from a well-established healthcare system, heightened awareness of menstrual health issues, and a growing adoption of advanced medical technologies. There has been a notable increase in the demand for non-invasive and drug-free therapies, such as TENS devices, heat therapy products, and wearable pain relief solutions. Furthermore, an increasing emphasis on women's health, favorable regulatory policies, and rising investments in R&D for innovative menstrual pain management solutions are fueling market growth.
Moreover, the presence of leading companies like iPulse Medical, the manufacturer of Livia, an FDA-approved wearable device utilizing TENS to offer immediate relief from menstrual cramps, demonstrates how technological advancements and consumer demand for convenient, non-drug solutions are propelling the U.S. market.
As a result, these factors are expected to significantly drive the growth of the dysmenorrhea treatment market in North America over the forecast period from 2025 to 2032.
To know more about why North America is leading the market growth in the dysmenorrhea treatment market, get a snapshot of the Dysmenorrhea Treatment Market Outlook
Dysmenorrhea Treatment Market Dynamics
The dysmenorrhea treatment market is witnessing robust growth, driven by the rising prevalence of menstrual disorders and the increasing focus on women's health globally. Dysmenorrhea, characterized by painful menstruation, is highly prevalent among adolescent girls and women of reproductive age. This large patient base creates significant demand for effective treatment options. Over-the-counter (OTC) medications such as NSAIDs, prescription hormonal therapies like oral contraceptives, and newer non-pharmacological options such as transcutaneous electrical nerve stimulation (TENS) and dietary supplements form the current market landscape. Additionally, a growing interest in personalized and integrative approaches, including acupuncture and lifestyle modifications, is adding further diversity to the treatment landscape.
Market dynamics are also shaped by increasing awareness and the gradual destigmatization of menstrual health issues. Educational campaigns, better diagnosis rates, and healthcare provider initiatives are encouraging more women to seek treatment rather than endure symptoms in silence. This positive shift in societal attitudes is contributing to a higher diagnosis rate and, consequently, expanding the market for dysmenorrhea therapies. Moreover, digital health platforms and telemedicine services are improving access to gynecological consultations, particularly in emerging markets, where access to specialized care was traditionally limited.
On the competitive front, the market features a mix of established pharmaceutical companies, consumer healthcare brands, and emerging startups. While OTC NSAIDs remain the first-line therapy, the hormonal therapy segment is gaining traction due to its dual benefits of contraception and menstrual pain management. However, hormonal treatments are associated with side effects and contraindications, prompting a surge in research and development activities for novel, safer, and more targeted therapeutics. Startups and wellness brands are also tapping into consumer demand for natural and plant-based solutions, further intensifying market competition.
Despite its growth potential, the dysmenorrhea treatment market faces certain challenges. Barriers such as high costs of advanced hormonal therapies, limited insurance coverage in some regions, and cultural stigmas in conservative societies can hinder treatment uptake. Furthermore, many women opt for home remedies or endure the pain without seeking medical intervention, limiting the addressable market. Ongoing clinical trials for novel non-hormonal therapies and personalized medicine approaches hold promise, but these therapies may take time to gain regulatory approvals and widespread acceptance.
In summary, the dysmenorrhea treatment market is poised for steady growth, supported by a large patient base, increasing awareness, and a broadening range of treatment options. Strategic partnerships, R&D investments, and patient education will play pivotal roles in overcoming existing barriers and unlocking further growth opportunities in this market. As the focus on women's health continues to rise globally, the market is expected to see continued innovation and diversification in treatment modalities.
Get a sneak peek at the dysmenorrhea treatment market dynamics @ Dysmenorrhea Treatment Market Trends Report Metrics Details Coverage Global Study Period 2022–2032 Dysmenorrhea Treatment Market CAGR ~7% Dysmenorrhea Treatment Market Size by 2032 ~USD 8 Billion Key Dysmenorrhea Treatment Companies Johnson & Johnson Services Inc., iPulse Medical Ltd., Bridges CHC, LLC., AbbVie Inc., Myoovi Ltd., Rael Inc., Abbott, Pfizer Inc., TensCare Ltd. (UK), Beurer GmbH (Germany), BPL Medical Technologies, Cora, Carex Health Brands (USA), Sumitovant Biopharma, Emcure Pharmaceuticals, Everteen, Samphire Neuroscience, Mirapulse, Welme, Nomisk, among others
Dysmenorrhea Treatment Market Assessment Dysmenorrhea Treatment Market Segmentation Dysmenorrhea Treatment Market Segmentation By Type: Primary Dysmenorrhea and Secondary Dysmenorrhea Dysmenorrhea Treatment Market Segmentation By Route of Treatment: Drugs, Devices, and Others Dysmenorrhea Treatment Market Segmentation By End-User: Hospitals, Gynecology & Wellness Clinics, and Homecare Settings Dysmenorrhea Treatment Market Segmentation By Geography : North America, Europe, Asia-Pacific, and Rest of World
Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the dysmenorrhea treatment market are set to emerge as the trendsetter explore @ Dysmenorrhea Treatment Options
Table of Contents 1 Dysmenorrhea Treatment Market Report Introduction 2 Dysmenorrhea Treatment Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 Dysmenorrhea Treatment Market Key Factors Analysis 6 Dysmenorrhea Treatment Market Porter's Five Forces Analysis 7 Dysmenorrhea Treatment Market Layout 8 Dysmenorrhea Treatment Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us
Interested in knowing the dysmenorrhea treatment market by 2032? Click to get a snapshot of the Dysmenorrhea Treatment Market Analysis
Related Reports
Dysmenorrhea Market
Dysmenorrhea Market Insights, Epidemiology, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key dysmenorrhea companies, including Daewon Pharmaceutical, PNB Vesper Life Science, Nobelpharma, among others.
Dysmenorrhea Pipeline
Dysmenorrhea Pipeline Insight – 2025 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key dysmenorrhea companies, including Ionis Pharmaceuticals, 1ST Biotherapeutics, Scholar Rock, Revalesio, QurAlis Corporation, Sanofi, MediciNova, Helixmith, Verge Genomics, UCB, among others.
Non-Steroidal Anti-Inflammatory Drugs Market
Non-Steroidal Anti-Inflammatory Drugs Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key NSAIDs companies, including Pfizer Inc., Johnson & Johnson Services, Inc., Bayer AG, Sanofi, GSK plc., Heron Therapeutics, Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Ltd., Reckitt Benckiser Group PLC., Assertio Holdings, Inc., AstraZeneca, Boehringer Ingelheim Ltd., Assertio Holdings, Inc., Horizon Therapeutics plc, Perrigo Company plc, Viatris Inc., Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Eli Lilly and Company, among others.
Contraceptives Market
Contraceptives Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key contraceptives companies, including Teva Pharmaceutical Industries Ltd, TherapeuticsMD, Inc., AbbVie Inc., Bayer AG, The Cooper Companies Inc., FemCap Inc, Veru Inc., Meril Life Sciences Pvt. Ltd., Pregna International Limited., Reckitt Benckiser Group PLC., Viatris Inc., EUROGINE, S.L, Gedeon Richter Plc., Agile Therapeutics., Evofem Biosciences, Inc., Amneal Pharmaceuticals LLC., Shanghai Dahua Pharmaceutical Co., Ltd., Pfizer Inc., Contech Devices Private Limited, Cupid Limited, among others.
Menstrual Cups Market
Menstrual Cups Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key menstrual cups companies, including Redcliffe Hygiene Private Limited, The Keeper, Inc., Lena Cup, INTIMINA, Blossom Cup, Mooncup Ltd, PEPTONIC Medical, YUUKI Company s.r.o., Anigan, LadyCup, Me Luna GmbH, The Flex Company, Procter & Gamble, Diva International Inc., Saalt, among others.
DelveInsight's Pharma Competitive Intelligence Service: Through its CI solutions, DelveInsight provides its clients with real-time and actionable intelligence on their competitors and markets of interest to keep them stay ahead of the competition by providing insights into the latest therapeutic area-specific/indication-specific market trends, in emerging drugs, and competitive strategies. These services are tailored to the specific needs of each client and are delivered through a combination of reports, dashboards, and interactive presentations, enabling clients to make informed decisions, mitigate risks, and identify opportunities for growth and expansion.
Other Business Pharmaceutical Consulting Services
Healthcare Conference Coverage
Pipeline Assessment
Healthcare Licensing Services
Discover how a mid-pharma client gained a level of confidence in their soon-to-be partner for manufacturing their therapeutics by downloading our Due Diligence Case Study
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
7 hours ago
- Business Upturn
Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
Doptelet Sprinkle (avatrombopag) was approved as an effective formulation for children one year to less than six years. The primary endpoint was met in 27.8% of patients, confirming the efficacy in children and adolescents with persistent or chronic ITP WALTHAM, Mass., July 25, 2025 (GLOBE NEWSWIRE) — Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration (FDA) approved Doptelet® (avatrombopag) for the treatment of thrombocytopenia in pediatric patients one year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to a prior therapy. 1 The approval also includes a new formulation, Doptelet Sprinkle (avatrombopag) oral granules, for use in children ages one to less than six years. 1 'Doptelet represents a significant advancement in the treatment of children and adolescents with persistent or chronic ITP,' said Rachael Grace, MD, MMSc, Pediatric Hematologist and Director, Hematology Clinical Research at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, and lead investigator of the AVA-PED-301 study. 'This therapy offers simple, flexible administration because it is oral, available as a tablet and now as a new pediatric sprinkle formulation and has no food restrictions. The approval of Doptelet for pediatric ITP offers families a new treatment option that can help address challenges in managing ITP in pediatric patients.' Doptelet Sprinkle is the approved dosage form for patients aged one to less than six years, while Doptelet tablet is the approved dosage form for patients aged six and up. 1 The pediatric approval is based on results from AVA-PED-301, a global, randomized, phase 3 study evaluating the efficacy, safety, and pharmacokinetics of Doptelet in the treatment of pediatric subjects with ITP. The study showed that 27.8% of Doptelet patients achieved the primary endpoint of durable platelet response* versus 0% of placebo patients in the absence of rescue medication (p=0.0077, 95% CI 15.8-39.7). Also, 81.5% of Doptelet patients achieved the alternative primary endpoint of platelet response** versus no patients in the placebo group (p=<0.0001, 95% CI 71.1-91.8). At Day 8, 55.6% of Doptelet patients (95% CI: 41.4%, 69.1%) had a platelet count ≥50×10^9/L in the absence of rescue therapy (p<0.0001) versus no placebo patients (95% CI: 0.0%, 16.1%). Doptelet was generally well-tolerated. In pediatric patients with persistent or chronic immune thrombocytopenia, the most common adverse reactions (≥ 10%) were viral infection, nasopharyngitis, cough, pyrexia, and oropharyngeal pain.1 'Since its introduction in 2019, Doptelet has been a cornerstone therapy for chronic ITP in adults,' said Duane Barnes, President of Sobi North America. 'This approval not only reinforces our commitment to innovation but also allows us to expand the treatment experience for patients and their families by offering Doptelet in two formulations.' Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by low numbers of platelets, leading to bruising and an increased risk of bleeding. It is estimated up to 100 people per million live with ITP. In children, ITP occurs in five out of 100,000 children per year and up to 25% of newly diagnosed pediatric ITP patients develop chronic ITP. Currently, no cure is available, and patients usually relapse after various treatments. Indications Doptelet is a thrombopoietin receptor agonist indicated for the treatment of: Thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure. Thrombocytopenia in adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment Thrombocytopenia in pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia who have had an insufficient response to a previous treatment Important Safety Information Doptelet is a thrombopoietin (TPO) receptor agonist and TPO receptor agonists have been associated with thrombotic and thromboembolic complications in patients with chronic liver disease or immune thrombocytopenia. In patients with chronic liver disease, thromboembolic events (portal vein thrombosis) occurred in 0.4% (1/274) of patients receiving Doptelet. In adult patients with chronic immune thrombocytopenia, thromboembolic events (arterial or venous) occurred in 7% (9/128) of patients receiving Doptelet. Doptelet should not be administered to patients with chronic liver disease or immune thrombocytopenia in an attempt to normalize platelet counts. The most common adverse reactions in clinical trials were viral infection, nasopharyngitis, cough, pyrexia, and oropharyngeal pain. To report SUSPECTED ADVERSE REACTIONS, contact Sobi, Inc. at 1-866-773-5274 or FDA at 1-800-FDA-1088 or Please see the full Prescribing Information for Doptelet. * A durable response consisted of patients achieving a platelet count >=50,000/uL for six of the last eight weeks in the 12-week core phase of the AVA-PED-301 study. ** Efficacy was also evaluated by platelet response, defined as the proportion of subjects achieving at least two consecutive platelet assessments ≥50×10^9/L in the core phase in the absence of rescue medication. About Immune thrombocytopenia (ITP) Immune thrombocytopenia (ITP) is a rare, acquired autoimmune condition characterized by a low platelet count and an increased risk of bleeding, and represents a multi-faceted disease burden for children and adolescents. Bleeding can range from minor symptoms, such as bruising, to more severe findings such as intracranial hemorrhage. ITP can also have a significant impact on quality of life including severe fatigue and restrictions on physical activity due to risk of bleeding. About Doptelet® (avatrombopag) Doptelet is an orally administered thrombopoietin receptor agonist (TPO-RA) that mimics the biologic effects of TPO in stimulating the development and maturation of megakaryocytes, resulting in increased platelet count. It is approved by the US Food & Drug Administration (FDA) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure and by the European Medicines Agency (EMA) for the treatment of severe thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo an invasive procedure. In June 2019, Doptelet was approved by the FDA for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment and in 2021, Doptelet was approved by EMA for the treatment of primary chronic ITP in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins). About Sobi North America As the North American affiliate of international biopharmaceutical company Sobi, the Sobi North America team is committed to Sobi's vision of being a leader in providing innovative treatments that transform lives for individuals with rare diseases. Our product portfolio includes multiple approved treatments focused on immunology, hematology and specialty care. With U.S. headquarters in the Boston area, Canadian headquarters in the Toronto area, and field sales, medical and market access representatives spanning North America, our growing team has a proven track record of commercial excellence. More information is available at or at About Sobi® Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi's share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at and LinkedIn. Contacts For details on how to contact the Sobi Investor Relations Team, please click here. For Sobi Media, click here. References 1. Doptelet Prescribing Information. Doptelet U.S. Product Information. Last updated: July 2025. Morrisville, NC: AkaRx, Inc. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
7 hours ago
- Yahoo
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
Sujata Setia, Mithail Afrige Chowdhury and Steve Gschmeissner awarded £10,000 each for images exploring domestic abuse, climate migration and the hidden dangers of cholesterol A Thousand Cuts, Sujata Setia, 2023, Urban Travel, Mithail Afrige Chowdhury, 2023, Cholesterol in the Liver, 2022, Steve Gschmeissner Click Here to download press images and captions LONDON, July 25, 2025 (GLOBE NEWSWIRE) -- Wellcome's 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and street photographer Mithail Afrige Chowdhury, and UK-based electron microscopy specialist and science photographer Steve Gschmeissner have each been awarded a £10,000 prize for powerful images that reflect how science and health shape people's lives in complex and deeply personal ways, from the from the hidden toll of domestic abuse to the everyday realities of climate migration, to the microscopic processes that underpin heart disease. Now in its 28th year, the Wellcome Photography Prize celebrates compelling imagery at the intersection of science, health and human experience. From documentary photography to microscopy and medical imaging, it highlights diverse perspectives on global health and the vital role of visual storytelling in creating a healthier future. The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025. Each of the finalists has received a £1,000 prize, with a total of £52,000 awarded across the competition. Lara Clements, Associate Director, Engagement, Wellcome, says, 'The Wellcome Photography Prize offers image-makers a platform to showcase the impact of science and health on lives around the world. This year's winning works stood out not only for their technical accomplishment, but for the care and collaboration behind them. Sujata Setia's portraits raised powerful questions around dignity, confidentiality and sensitivity. Mithail Afrige Chowdhury's image exemplified the value of being embedded in the community and explored themes of adaptation, illusion and fantasy in a compelling way. Steve Gschmeissner's biomedical image impressed us with its precision and raised important questions about how scientific imagery is shared and understood by the public. We hope audiences will find the winners' work moving, educational and inspiring, and enjoy the full exhibition at the Francis Crick Institute.' The Winners In the Storytelling Series category, Sujata Setia was recognised for A Thousand Cuts, a deeply collaborative portrait project developed with survivors of domestic abuse within South Asian communities. Each image is a composite of personal testimony, visual symbolism, and traditional craft. Setia worked with the women and with the charity SHEWISE to create portraits that protected anonymity without erasing identity, applying the Indian paper-cutting technique sanjhi to overlay each photograph. The results are intimate, powerful reflections on generational trauma, silence, survival, and the politics of representation. From the account of a woman forced into marriage twice by her father and left with lasting PTSD, to a mother determined to break the cycle of violence for her daughter, the series captures how abuse can become ingrained and normalised, and how art can offer a means of reclaiming narrative. Sujata Setia says, 'This is a monumental recognition. A Thousand Cuts being selected for Wellcome Photography Prize affirms that health cannot be separated from the histories that shape it. And that domestic abuse is never a singular event; it leaves a direct, trans-generational imprint on health. As a child who grew up in a home where violence was a daily occurrence, I carry that trauma like another limb. This recognition validates not just my story, but the invisible, intangible, yet deeply scarring legacy of gender-based abuse. Domestic abuse is one of the most widespread global crimes; and yet remains among the least publicly acknowledged health crises. I hope this moment becomes a catalyst for deeper dialogue and scholarship around the interrelation between domestic abuse and health. That is our collective hope.' Mithail Afrige Chowdhury was awarded the Striking Solo Photography prize for Urban Travel, a deceptively gentle image of a mother and daughter on a rooftop picnic in Dhaka. With few parks left in the city due to rapid urbanisation, this staged moment, a simple attempt to give a child a taste of nature, becomes an act of resilience. Nearly half of Dhaka's population today are climate migrants, displaced by increasingly extreme weather, and Chowdhury's work highlights the everyday consequences of these shifts: the loss of green space, of childhood rituals, of breath. The photograph is tender, composed, and yet filled with tension, a portrait of care and adaptation under invisible pressures. Mithail Afrige Chowdhury says, 'When I got the news, the first thing I did was charge my camera—not to take a photo, but to restart something I thought I'd lost. I won't dwell on personal or professional hardships, but this moment means more than I can say. I made this image two years ago, as part of a major project on climate change, urban sustainability, and public health. Then life intervened, and fear slowly pulled me away from the work I loved. But now, I can wake up with an objective. Because someone has my back. And that makes all the difference. Awards can feel technical but this recognition from Wellcome feels deeply human.' The winner of The Marvels of Scientific and Medical Imaging was announced as Steve Gschmeissner, whose electron microscopy image Cholesterol in the Liver reveals cholesterol crystals (shown in blue) forming inside lipid-laden liver cells (purple). These microscopic shifts, invisible to the naked eye, can have deadly consequences: when cholesterol hardens from liquid to crystal, it damages blood vessels and contributes to heart disease and strokes. Gschmeissner's colourised SEM image transforms this biological process into something visually striking, part data, part artwork. With a career spanning over four decades, and more than 10,000 images published in scientific journals, stamp collections, fashion collaborations, and music albums, his work exemplifies how imaging can bridge science and culture. Steve Gschmeissner says, 'When I discovered that Wellcome had reintroduced the Marvels of Scientific and Medical Imaging category, I was delighted to enter such a prestigious competition. I was thrilled to be shortlisted, and winning first prize is undoubtedly one of the highlights of my 50-year career of trying to bring the wonders of the microscopic world to all.' This year's prize drew submissions from over 100 countries. The Top 25 entries featured over 30 individuals from 18 countries, spanning Bangladesh, Brazil, France, Germany, Greece, India, Italy, Myanmar, Peru, South Africa, Spain, Uganda, the UK, USA and beyond. The winners were selected by an international judging panel comprising leading voices from photography, science, health and journalism. The panel was chaired by Melanie Keen, Director of Wellcome Collection, and included Caroline Hunter, Picture Editor at The Guardian; Daniella Zalcman, Photographer and Founder of Women Photograph; Benjamin Ryan, Independent Science Journalist; Elizabeth Wathuti, Environmental and Climate Activist; Esmita Charani, Associate Professor at the University of Cape Town; Helen Fisher, Professor of Developmental Psychopathology at King's College London; Noah Green, Science Educator at the Beautiful Biology Initiative; and Mark Lythgoe, Director of the UCL Centre for Advanced Biomedical Imaging. Wellcome Photography Prize Exhibition Curated by Laurie Britton Newell and Ligaya Salazar, the Wellcome Photography Prize exhibition features images that reflect a wide spectrum of health experiences, from everyday routines to global challenges. Using techniques such as portraiture, cyanotypes, drone photography, and light and electron microscopy, the image makers show how health is lived, documented and researched around the world. Many of the works respond to Wellcome's core focus areas, mental health, climate and health, infectious disease and discovery research. Together, they reveal how these issues overlap and take shape in different cultural and geographic contexts. The result is a layered and often unexpected portrait of health today, told through voices and perspectives that are frequently overlooked. Among this year's highlights are Marks of Majesty: Vanessa by Julia Comita and Stephanie Francis, a portrait honouring the life and choices of a person impacted by breast cancer who opted for aesthetic flat closure, challenging assumptions around gender, illness and identity. Beautiful Disaster by Alexandru Radu Popescu shows a lake of toxic mining waste in Romania that continues to expand each year, an image of both striking beauty and environmental damage. Resilience Artist by Pyaephyo Thetpaing captures a craftsman in Myanmar who creates lacquerware using his foot, offering a broader reflection on health, disability and the role of cultural tradition in healing. In the scientific imaging category, Ice and Fire Chronics by Ingrid Augusto, Kildare Rocha de Miranda and Vânia da Silva Vieira shows the structure of the parasite that causes Chagas disease, which affects millions across the Americas. Blooming Barrier by Lucy Holland presents goblet cells inside the gut of a child with Hirschsprung's disease, offering insight into how cell structures influence lifelong digestive health. From Butterflies to Humans by Amaia Alcalde Anton reveals the brain of a butterfly mid-metamorphosis, part of a study into neurogenesis with implications for human brain development. In addition to the Top 25 entries, the exhibition also features Things We Left Unseen, a youth-led photography project developed by Cape Town-based public health organisation Eh!woza. Created in collaboration with young people in the township of Khayelitsha, the project explores health, stigma, and daily life through the eyes of a generation growing up with high HIV and TB burdens, but also with hope and agency. The exhibition is hosted at the Francis Crick Institute, reflecting a shared commitment to making science more visible through culture. Ali Bailey, Director of Communications and Public Engagement at the Francis Crick Institute, said: 'We are delighted to host the top images from the Wellcome Photography Prize, showcasing the power of visual storytelling in health and science. The images explore a number of themes that resonate with Crick research, from the health effects of air pollution to neurogenesis. We hope visitors will be moved by the stories behind these incredible photos and also inspired by how beautiful science can be.' Notes to Editors: Media Contacts Sophie Balfour-LynnSuttonSophiebl@ Mary-Kate FindonWellcomemediaoffice@ Winners' Biographies Sujata Setia (Storytelling Series) Sujata Setia is an Indian-born, UK-based artist who's socially engaged, research-led practice combines photography with traditional artistic interventions to explore subaltern histories, cultural imperialism, and the politics of representation. With a background in journalism and a Master's in International Relations from King's College London, her work draws on academic research and community collaboration to centre marginalised voices, particularly through a feminist lens. Her acclaimed series Changing the Conversation marked a shift away from her earlier portraiture, interrogating the cultural and political construction of beauty. In 2024, she was awarded the Culture King's Grant to develop a lens-based, interdisciplinary project exploring the role of workplace structures for embroidery women artisans in Kashmir. She also recently received the Centre for British Photography Realisation Grant to further expand the scope of A Thousand Cuts, a powerful body of work amplifying the voices of survivors of gender-based abuse. Setia's work has received major international recognition, including the Sony World Photography Award (Creative category, 2024), LensCulture Critics' Choice Award (2024), Prix Pictet nomination (2023), BJP Female in Focus (2022), and Photographer of the Year at the Tokyo International Foto Awards (2021). Her photography has been exhibited widely—from Somerset House in London to Times Square in New York—and featured in leading publications including The Guardian, CNN, BBC, and Forbes. Beyond her visual practice, Setia contributes to education and advocacy through teaching ethical storytelling and photography at EFTI in Madrid, and through collaborations with organisations such as SHEWISE and WERESTART in the UK. Her work consistently seeks to reshape public narratives around identity, power, and care through interdisciplinary, justice-focused art. Mithail Afrige Chowdhury (Striking Solo Photography) Mithail Afrige Chowdhury is a documentary and street photographer based in Dhaka, Bangladesh. Raised in the city of Khulna, his photography is deeply rooted in the lives of ordinary people. 'Since then, I have always tried to understand people's lives—their pain, joy, and the complexities shaped by social, economic, political, and environmental changes.' He began photography in 2015 and chose to document what he knew best: life around him. His work has captured the Rohingya refugee crisis, the effects of climate change on Bangladesh (an ongoing project), major festivals, urban water crises, slum fires, and the Covid-19 pandemic. Mithail has won numerous international photography awards, including the Life Press Photo Award (Ukraine), Xposure International Photography Competition (UAE), Compass Photo Competition by the University of Oxford (UK), and contests in China. His work has been featured in The Guardian, The Daily Sun, The Times of India, Global Photography, and publications from the University of Oxford, ASCE, and Saturday Magazine. Steve Gschmeissner (The Marvels of Medical and Scientific Imaging) Steve Gschmeissner is a UK-based photographer and electron microscopy specialist whose career spans over four decades in scientific imaging. After earning a degree in Zoology, he spent 25 years at the Royal College of Surgeons, eventually leading the electron microscopy services, followed by 15 years leading the EM unit at Cancer Research UK. In 2002, Gschmeissner retired early to dedicate himself to freelance photography, specialising in Scanning Electron Microscopy (SEM). Over the past two decades, he has built an archive of more than 10,000 images, widely published across scientific, medical, and popular media. His work has featured in everything from textbooks and advertising to art, fashion, and music, appearing on album covers for Peter Gabriel, artworks by Damien Hirst, on US Postal Service stamps, and as visual inspiration for an Iris van Herpen's fashion collection. In 2021, he was awarded the Lennart Nilsson Award for his lifelong contribution to microscopy. His images continue to bridge the worlds of science and visual culture, offering new ways of seeing the invisible. Full list of Finalists - Top 25 Entries Striking solo photography Searching for Life – Sandipani Chattopadhyay (India) Urban Travel – Mithail Afrige Chowdhury (Bangladesh) Marks of Majesty: Vanessa – Julia Comita & Stephanie Francis (USA) Musa – Marijn Fidder (Uganda/Netherlands) The Light Will Come – Dora Grivopoulou (Greece) Cricket is My Emotion – Ziaul Huque (Bangladesh) Pie-by-Sam – Reatile Moalusi (South Africa) Beautiful Disaster – Alexandru Radu Popescu (Romania) Resilience Artist – Pyaephyo Thetpaing (Myanmar) Stereo EEG Self-Portrait – Muir Vidler (UK) Transparent Curtains – Oded Wagenstein (Israel) Self, Five Years On – Georgie Wileman (UK) A storytelling series The Loss Mother's Stone – Nancy Borowick (US Virgin Islands) A Dream to Cure Water – Ciril Jazbec (UK) Nemo's Garden – Giacomo d'Orlando (Italy) A Thousand Cuts – Sujata Setia (UK) I Spend 150 Hours Alone Each Week – Madeleine Waller (Australia/UK) The marvels of scientific and medical imaging From Butterflies to Humans – Amaia Alcalde Anton (UK) Ice and Fire Chronics: The Chagas Disease Invader – Ingrid Augusto, Kildare Rocha de Miranda & Vânia da Silva Vieira (Brazil) Cholesterol in the Liver – Steve Gschmeissner (UK) Blooming Barrier – Lucy Holland (UK) Submarine Fever – Jander Matos & Joaquim Nascimento (Brazil) Organoids – Oliver Meckes & Nicole Ottawa, Eye of Science (Germany) I've Got You, Under My Skin: Microplastics in Mammalian Tissue – P. Stephen Patrick & Olumide Ogunlade (UK) Brixton Road, Lambeth – Marina Vitaglione (France/UK) Exhibition Details Wellcome Photography Prize 2025 exhibition is curated by Laurie Britton Newell and Ligaya SalazarAt the Francis Crick Institute, 1 Midland Road, London, NW1 1AT17 July – 18 October 2025Open Wednesdays to Saturdays, 10am-4pm (Wednesdays until 8pm)Admission free About Wellcome Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease and climate and health. Follow the prize:Instagram: @wellcomephotoprize Wellcome Photography Prize 2025 | Wellcome About the Francis Crick Institute We are delighted that the Crick are hosting this year's Wellcome Photography Prize exhibition. The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London. The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe. A photo accompanying this announcement is available at
Business Upturn
7 hours ago
- Business Upturn
Wellcome Photography Prize 2025: Winning Images Reveal Powerful Stories of Science and Health
By GlobeNewswire Published on July 25, 2025, 15:19 IST A Thousand Cuts, Sujata Setia, 2023, Urban Travel, Mithail Afrige Chowdhury, 2023, Cholesterol in the Liver, 2022, Steve Gschmeissner Click Here to download press images and captions LONDON, July 25, 2025 (GLOBE NEWSWIRE) — Wellcome's 2025 Photography Prize celebrates three image makers whose work reveals the human stories behind science and health. UK-based artist Sujata Setia, Bangladeshi documentary and street photographer Mithail Afrige Chowdhury, and UK-based electron microscopy specialist and science photographer Steve Gschmeissner have each been awarded a £10,000 prize for powerful images that reflect how science and health shape people's lives in complex and deeply personal ways, from the from the hidden toll of domestic abuse to the everyday realities of climate migration, to the microscopic processes that underpin heart disease. Now in its 28th year, the Wellcome Photography Prize celebrates compelling imagery at the intersection of science, health and human experience. From documentary photography to microscopy and medical imaging, it highlights diverse perspectives on global health and the vital role of visual storytelling in creating a healthier future. The top 25 entries are now on display in the Wellcome Photography Prize 2025 exhibition, which is free and open to the public at the Francis Crick Institute in London, running until 18 October 2025. Each of the finalists has received a £1,000 prize, with a total of £52,000 awarded across the competition. Lara Clements, Associate Director, Engagement, Wellcome, says, ' The Wellcome Photography Prize offers image-makers a platform to showcase the impact of science and health on lives around the world. This year's winning works stood out not only for their technical accomplishment, but for the care and collaboration behind them. Sujata Setia's portraits raised powerful questions around dignity, confidentiality and sensitivity. Mithail Afrige Chowdhury's image exemplified the value of being embedded in the community and explored themes of adaptation, illusion and fantasy in a compelling way. Steve Gschmeissner's biomedical image impressed us with its precision and raised important questions about how scientific imagery is shared and understood by the public. We hope audiences will find the winners' work moving, educational and inspiring, and enjoy the full exhibition at the Francis Crick Institute.' The Winners In the Storytelling Series category, Sujata Setia was recognised for A Thousand Cuts , a deeply collaborative portrait project developed with survivors of domestic abuse within South Asian communities. Each image is a composite of personal testimony, visual symbolism, and traditional craft. Setia worked with the women and with the charity SHEWISE to create portraits that protected anonymity without erasing identity, applying the Indian paper-cutting technique sanjhi to overlay each photograph. The results are intimate, powerful reflections on generational trauma, silence, survival, and the politics of representation. From the account of a woman forced into marriage twice by her father and left with lasting PTSD, to a mother determined to break the cycle of violence for her daughter, the series captures how abuse can become ingrained and normalised, and how art can offer a means of reclaiming narrative. Sujata Setia says, ' This is a monumental recognition. A Thousand Cuts being selected for Wellcome Photography Prize affirms that health cannot be separated from the histories that shape it. And that domestic abuse is never a singular event; it leaves a direct, trans-generational imprint on health. As a child who grew up in a home where violence was a daily occurrence, I carry that trauma like another limb. This recognition validates not just my story, but the invisible, intangible, yet deeply scarring legacy of gender-based abuse. Domestic abuse is one of the most widespread global crimes; and yet remains among the least publicly acknowledged health crises. I hope this moment becomes a catalyst for deeper dialogue and scholarship around the interrelation between domestic abuse and health. That is our collective hope.' Mithail Afrige Chowdhury was awarded the Striking Solo Photography prize for Urban Travel , a deceptively gentle image of a mother and daughter on a rooftop picnic in Dhaka. With few parks left in the city due to rapid urbanisation, this staged moment, a simple attempt to give a child a taste of nature, becomes an act of resilience. Nearly half of Dhaka's population today are climate migrants, displaced by increasingly extreme weather, and Chowdhury's work highlights the everyday consequences of these shifts: the loss of green space, of childhood rituals, of breath. The photograph is tender, composed, and yet filled with tension, a portrait of care and adaptation under invisible pressures. Mithail Afrige Chowdhury says, ' When I got the news, the first thing I did was charge my camera—not to take a photo, but to restart something I thought I'd lost. I won't dwell on personal or professional hardships, but this moment means more than I can say. I made this image two years ago, as part of a major project on climate change, urban sustainability, and public health. Then life intervened, and fear slowly pulled me away from the work I loved. But now, I can wake up with an objective. Because someone has my back. And that makes all the difference. Awards can feel technical but this recognition from Wellcome feels deeply human.' The winner of The Marvels of Scientific and Medical Imaging was announced as Steve Gschmeissner, whose electron microscopy image Cholesterol in the Liver reveals cholesterol crystals (shown in blue) forming inside lipid-laden liver cells (purple). These microscopic shifts, invisible to the naked eye, can have deadly consequences: when cholesterol hardens from liquid to crystal, it damages blood vessels and contributes to heart disease and strokes. Gschmeissner's colourised SEM image transforms this biological process into something visually striking, part data, part artwork. With a career spanning over four decades, and more than 10,000 images published in scientific journals, stamp collections, fashion collaborations, and music albums, his work exemplifies how imaging can bridge science and culture. Steve Gschmeissner says, ' When I discovered that Wellcome had reintroduced the Marvels of Scientific and Medical Imaging category, I was delighted to enter such a prestigious competition. I was thrilled to be shortlisted, and winning first prize is undoubtedly one of the highlights of my 50-year career of trying to bring the wonders of the microscopic world to all.' This year's prize drew submissions from over 100 countries. The Top 25 entries featured over 30 individuals from 18 countries, spanning Bangladesh, Brazil, France, Germany, Greece, India, Italy, Myanmar, Peru, South Africa, Spain, Uganda, the UK, USA and beyond. The winners were selected by an international judging panel comprising leading voices from photography, science, health and journalism. The panel was chaired by Melanie Keen, Director of Wellcome Collection, and included Caroline Hunter, Picture Editor at The Guardian ; Daniella Zalcman, Photographer and Founder of Women Photograph; Benjamin Ryan, Independent Science Journalist; Elizabeth Wathuti, Environmental and Climate Activist; Esmita Charani, Associate Professor at the University of Cape Town; Helen Fisher, Professor of Developmental Psychopathology at King's College London; Noah Green, Science Educator at the Beautiful Biology Initiative; and Mark Lythgoe, Director of the UCL Centre for Advanced Biomedical Imaging. Wellcome Photography Prize Exhibition Curated by Laurie Britton Newell and Ligaya Salazar, the Wellcome Photography Prize exhibition features images that reflect a wide spectrum of health experiences, from everyday routines to global challenges. Using techniques such as portraiture, cyanotypes, drone photography, and light and electron microscopy, the image makers show how health is lived, documented and researched around the world. Many of the works respond to Wellcome's core focus areas, mental health, climate and health, infectious disease and discovery research. Together, they reveal how these issues overlap and take shape in different cultural and geographic contexts. The result is a layered and often unexpected portrait of health today, told through voices and perspectives that are frequently overlooked. Among this year's highlights are Marks of Majesty: Vanessa by Julia Comita and Stephanie Francis, a portrait honouring the life and choices of a person impacted by breast cancer who opted for aesthetic flat closure, challenging assumptions around gender, illness and identity. Beautiful Disaster by Alexandru Radu Popescu shows a lake of toxic mining waste in Romania that continues to expand each year, an image of both striking beauty and environmental damage. Resilience Artist by Pyaephyo Thetpaing captures a craftsman in Myanmar who creates lacquerware using his foot, offering a broader reflection on health, disability and the role of cultural tradition in healing. In the scientific imaging category, Ice and Fire Chronics by Ingrid Augusto, Kildare Rocha de Miranda and Vânia da Silva Vieira shows the structure of the parasite that causes Chagas disease, which affects millions across the Americas. Blooming Barrier by Lucy Holland presents goblet cells inside the gut of a child with Hirschsprung's disease, offering insight into how cell structures influence lifelong digestive health. From Butterflies to Humans by Amaia Alcalde Anton reveals the brain of a butterfly mid-metamorphosis, part of a study into neurogenesis with implications for human brain development. In addition to the Top 25 entries, the exhibition also features Things We Left Unseen , a youth-led photography project developed by Cape Town-based public health organisation Eh!woza. Created in collaboration with young people in the township of Khayelitsha, the project explores health, stigma, and daily life through the eyes of a generation growing up with high HIV and TB burdens, but also with hope and agency. The exhibition is hosted at the Francis Crick Institute, reflecting a shared commitment to making science more visible through culture. Ali Bailey, Director of Communications and Public Engagement at the Francis Crick Institute, said: ' We are delighted to host the top images from the Wellcome Photography Prize, showcasing the power of visual storytelling in health and science. The images explore a number of themes that resonate with Crick research, from the health effects of air pollution to neurogenesis. We hope visitors will be moved by the stories behind these incredible photos and also inspired by how beautiful science can be.' Notes to Editors: Media Contacts Sophie Balfour-LynnSutton [email protected] Mary-Kate FindonWellcome [email protected] Winners' Biographies Sujata Setia (Storytelling Series) Sujata Setia is an Indian-born, UK-based artist who's socially engaged, research-led practice combines photography with traditional artistic interventions to explore subaltern histories, cultural imperialism, and the politics of representation. With a background in journalism and a Master's in International Relations from King's College London, her work draws on academic research and community collaboration to centre marginalised voices, particularly through a feminist lens. Her acclaimed series Changing the Conversation marked a shift away from her earlier portraiture, interrogating the cultural and political construction of beauty. In 2024, she was awarded the Culture King's Grant to develop a lens-based, interdisciplinary project exploring the role of workplace structures for embroidery women artisans in Kashmir. She also recently received the Centre for British Photography Realisation Grant to further expand the scope of A Thousand Cuts , a powerful body of work amplifying the voices of survivors of gender-based abuse. Setia's work has received major international recognition, including the Sony World Photography Award (Creative category, 2024), LensCulture Critics' Choice Award (2024), Prix Pictet nomination (2023), BJP Female in Focus (2022), and Photographer of the Year at the Tokyo International Foto Awards (2021). Her photography has been exhibited widely—from Somerset House in London to Times Square in New York—and featured in leading publications including The Guardian , CNN , BBC , and Forbes . Beyond her visual practice, Setia contributes to education and advocacy through teaching ethical storytelling and photography at EFTI in Madrid, and through collaborations with organisations such as SHEWISE and WERESTART in the UK. Her work consistently seeks to reshape public narratives around identity, power, and care through interdisciplinary, justice-focused art. Mithail Afrige Chowdhury (Striking Solo Photography) Mithail Afrige Chowdhury is a documentary and street photographer based in Dhaka, Bangladesh. Raised in the city of Khulna, his photography is deeply rooted in the lives of ordinary people. 'Since then, I have always tried to understand people's lives—their pain, joy, and the complexities shaped by social, economic, political, and environmental changes.' He began photography in 2015 and chose to document what he knew best: life around him. His work has captured the Rohingya refugee crisis , the effects of climate change on Bangladesh (an ongoing project), major festivals, urban water crises, slum fires, and the Covid-19 pandemic. Mithail has won numerous international photography awards, including the Life Press Photo Award (Ukraine), Xposure International Photography Competition (UAE), Compass Photo Competition by the University of Oxford (UK), and contests in China. His work has been featured in The Guardian , The Daily Sun , The Times of India , Global Photography , and publications from the University of Oxford , ASCE , and Saturday Magazine . Steve Gschmeissner (The Marvels of Medical and Scientific Imaging) Steve Gschmeissner is a UK-based photographer and electron microscopy specialist whose career spans over four decades in scientific imaging. After earning a degree in Zoology, he spent 25 years at the Royal College of Surgeons, eventually leading the electron microscopy services, followed by 15 years leading the EM unit at Cancer Research UK. In 2002, Gschmeissner retired early to dedicate himself to freelance photography, specialising in Scanning Electron Microscopy (SEM). Over the past two decades, he has built an archive of more than 10,000 images, widely published across scientific, medical, and popular media. His work has featured in everything from textbooks and advertising to art, fashion, and music, appearing on album covers for Peter Gabriel, artworks by Damien Hirst, on US Postal Service stamps, and as visual inspiration for an Iris van Herpen's fashion collection. In 2021, he was awarded the Lennart Nilsson Award for his lifelong contribution to microscopy. His images continue to bridge the worlds of science and visual culture, offering new ways of seeing the invisible. Full list of Finalists – Top 25 Entries Striking solo photography Searching for Life – Sandipani Chattopadhyay (India) Urban Travel – Mithail Afrige Chowdhury (Bangladesh) Marks of Majesty: Vanessa – Julia Comita & Stephanie Francis (USA) Musa – Marijn Fidder (Uganda/Netherlands) The Light Will Come – Dora Grivopoulou (Greece) Cricket is My Emotion – Ziaul Huque (Bangladesh) Pie-by-Sam – Reatile Moalusi (South Africa) Beautiful Disaster – Alexandru Radu Popescu (Romania) Resilience Artist – Pyaephyo Thetpaing (Myanmar) Stereo EEG Self-Portrait – Muir Vidler (UK) Transparent Curtains – Oded Wagenstein (Israel) Self, Five Years On – Georgie Wileman (UK) A storytelling series The Loss Mother's Stone – Nancy Borowick (US Virgin Islands) A Dream to Cure Water – Ciril Jazbec (UK) Nemo's Garden – Giacomo d'Orlando (Italy) A Thousand Cuts – Sujata Setia (UK) I Spend 150 Hours Alone Each Week – Madeleine Waller (Australia/UK) The marvels of scientific and medical imaging From Butterflies to Humans – Amaia Alcalde Anton (UK) Ice and Fire Chronics: The Chagas Disease Invader – Ingrid Augusto, Kildare Rocha de Miranda & Vânia da Silva Vieira (Brazil) Cholesterol in the Liver – Steve Gschmeissner (UK) Blooming Barrier – Lucy Holland (UK) Submarine Fever – Jander Matos & Joaquim Nascimento (Brazil) Organoids – Oliver Meckes & Nicole Ottawa, Eye of Science (Germany) I've Got You, Under My Skin: Microplastics in Mammalian Tissue – P. Stephen Patrick & Olumide Ogunlade (UK) Brixton Road, Lambeth – Marina Vitaglione (France/UK) Exhibition Details Wellcome Photography Prize 2025 exhibition is curated by Laurie Britton Newell and Ligaya SalazarAt the Francis Crick Institute, 1 Midland Road, London, NW1 1AT17 July – 18 October 2025Open Wednesdays to Saturdays, 10am-4pm (Wednesdays until 8pm) Admission free About Wellcome Wellcome supports science to solve the urgent health challenges facing everyone. We support discovery research into life, health and wellbeing, and we're taking on three worldwide health challenges: mental health, infectious disease and climate and health. Follow the prize: Instagram: @wellcomephotoprize Wellcome Photography Prize 2025 | Wellcome About the Francis Crick Institute We are delighted that the Crick are hosting this year's Wellcome Photography Prize exhibition. The Francis Crick Institute is a biomedical discovery institute with the mission of understanding the fundamental biology underlying health and disease. Its work helps improve our understanding of why disease develops which promotes discoveries into new ways to prevent, diagnose and treat disease. An independent organisation, its founding partners are the Medical Research Council (MRC), Cancer Research UK, Wellcome, UCL (University College London), Imperial College London and King's College London. The Crick was formed in 2015, and in 2016 it moved into a brand new state-of-the-art building in central London which brings together 1500 scientists and support staff working collaboratively across disciplines, making it the biggest biomedical research facility under a single roof in Europe. A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
